ARTICLE | Clinical News
IL-7: Phase IIa started
May 23, 2011 7:00 AM UTC
Cytheris, Centre Leon Berard (Lyon, France) and ImmunID S.A.S. (Grenoble, France) began the double-blind, placebo-controlled, French Phase IIa ELYPSE-7 trial in 24 patients to evaluate an optimal dos...